These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9820992)

  • 1. Differences in the treatment of coronary heart disease between countries as revealed in the Scandinavian Simvastatin Survival Study (4S).
    Faergeman O; Kjekshus J; Cook T; Pyörälä K; Wilhelmsen L; Thorgeirsson G; Pedersen TR
    Eur Heart J; 1998 Oct; 19(10):1531-7. PubMed ID: 9820992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S).
    Strandberg TE; Pyörälä K; Cook TJ; Wilhelmsen L; Faergeman O; Thorgeirsson G; Pedersen TR; Kjekshus J;
    Lancet; 2004 Aug 28-Sep 3; 364(9436):771-7. PubMed ID: 15337403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S).
    Pyŏrälä K; Pedersen TR; Kjekshus J; Faergeman O; Olsson AG; Thorgeirsson G
    Diabetes Care; 1997 Apr; 20(4):614-20. PubMed ID: 9096989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering.
    Pedersen TR; Wilhelmsen L; Faergeman O; Strandberg TE; Thorgeirsson G; Troedsson L; Kristianson J; Berg K; Cook TJ; Haghfelt T; Kjekshus J; Miettinen T; Olsson AG; Pyörälä K; Wedel H
    Am J Cardiol; 2000 Aug; 86(3):257-62. PubMed ID: 10922429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing the risk of coronary events: evidence from the Scandinavian Simvastatin Survival Study (4S).
    Kjekshus J; Pedersen TR
    Am J Cardiol; 1995 Sep; 76(9):64C-68C. PubMed ID: 7572690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary artery disease: the Scandinavian Simvastatin Survival Study experience.
    Pedersen TR
    Am J Cardiol; 1998 Nov; 82(10B):53T-56T. PubMed ID: 9860376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S).
    Miettinen TA; Pyörälä K; Olsson AG; Musliner TA; Cook TJ; Faergeman O; Berg K; Pedersen T; Kjekshus J
    Circulation; 1997 Dec; 96(12):4211-8. PubMed ID: 9416884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study.
    Haffner SM; Alexander CM; Cook TJ; Boccuzzi SJ; Musliner TA; Pedersen TR; Kjekshus J; Pyörälä K
    Arch Intern Med; 1999 Dec 13-27; 159(22):2661-7. PubMed ID: 10597756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S).
    Lancet; 1995 May; 345(8960):1274-5. PubMed ID: 7746058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment.
    Wilhelmsen L; Pyörälä K; Wedel H; Cook T; Pedersen T; Kjekshus J
    Eur Heart J; 2001 Jul; 22(13):1119-27. PubMed ID: 11428852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol lowering after participation in the Scandinavian Simvastatin Survival Study (4S) in Finland.
    Strandberg TE; Lehto S; Pyörälä K; Kesäniemi A; Oksa H
    Eur Heart J; 1997 Nov; 18(11):1725-7. PubMed ID: 9402446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Scandinavian Simvastatin Survival Study (4S) subgroup analysis of diabetic subjects: implications for the prevention of coronary heart disease.
    Haffner SM
    Diabetes Care; 1997 Apr; 20(4):469-71. PubMed ID: 9096961
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).
    Lancet; 1994 Nov; 344(8934):1383-9. PubMed ID: 7968073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Scandinavian Simvastatin Survival Study: the clinical consequences].
    Larsen ML
    Rev Esp Cardiol; 1995; 48 Suppl 5():39-42. PubMed ID: 7494939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lp(a) lipoprotein level predicts survival and major coronary events in the Scandinavian Simvastatin Survival Study.
    Berg K; Dahlén G; Christophersen B; Cook T; Kjekshus J; Pedersen T
    Clin Genet; 1997 Nov; 52(5):254-61. PubMed ID: 9520115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).
    Girman CJ; Rhodes T; Mercuri M; Pyörälä K; Kjekshus J; Pedersen TR; Beere PA; Gotto AM; Clearfield M;
    Am J Cardiol; 2004 Jan; 93(2):136-41. PubMed ID: 14715336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of cholesterol lowering. Results from the Scandinavian Simvastatin Survival Study (4S).
    Jönsson B; Johannesson M; Kjekshus J; Olsson AG; Pedersen TR; Wedel H
    Eur Heart J; 1996 Jul; 17(7):1001-7. PubMed ID: 8809516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low high-density lipoprotein cholesterol and response to simvastatin therapy in Scandinavian Simvastatin Survival Study (4S).
    Robins S
    Circulation; 2002 Jul; 106(2):e8; author reply e8. PubMed ID: 12105176
    [No Abstract]   [Full Text] [Related]  

  • 19. Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiency.
    Chonchol M; Cook T; Kjekshus J; Pedersen TR; Lindenfeld J
    Am J Kidney Dis; 2007 Mar; 49(3):373-82. PubMed ID: 17336698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin compared to fluvastatin in the reduction of serum lipids and apolipoproteins in patients with ischaemic heart disease and moderate hypercholesterolaemia.
    Sigurdsson G; Haraldsdottir SO; Melberg TH; Tikkanen MJ; Miettinen TE; Kristianson KJ
    Acta Cardiol; 1998; 53(1):7-14. PubMed ID: 9638964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.